Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT04329325

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Mount Sinai Hospital New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

NCT03310918

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

NCT00736749

Conditions: Hematologic Diseases, Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, +4 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 164 locations

View Trial Details

Active, Not Recruiting

A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

NCT03467867

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia

NCT03431090

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions: Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Arizona Oncology Associates Tucson, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

University of California Irvine Health Orange, California, United States

View all 66 locations

View Trial Details

Active, Not Recruiting

Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma

NCT05411497

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Active, Not Recruiting

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Local Institution - 035 Hot Springs, Arkansas, United States

Local Institution - 641 Cerritos, California, United States

Local Institution - 681 Fountain Valley, California, United States

Local Institution - 047 Los Angeles, California, United States

View all 259 locations

View Trial Details

Active, Not Recruiting

Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya

NCT05233956

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases
Locations: Kangemi Health Center Nairobi, Kenya

View Trial Details

Active, Not Recruiting

Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients

NCT04108624

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University Of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions